ProQR Therapeutics (PRQR) Net Income Attributable to Noncontrolling Interests (2016 - 2023)
ProQR Therapeutics (PRQR) reported Income from Non-Controlling Interests of -$12.89 million for the quarter ended Sep 30, 2025, compared with -$9.32 million a year earlier.
Powered by 
Analysis
ProQR Therapeutics (PRQR) Net Income Attributable to Noncontrolling Interests (2016 - 2023) Analysis & Trends
Over the twelve months ended Sep 30, 2025, ProQR Therapeutics' Income from Non-Controlling Interests came in at -$47.76 million; for the year ended Dec 31, 2023, it was $415,380, up 79.1% from the prior year.
- By year, Income from Non-Controlling Interests came in at $231,870 in the year ended Dec 31, 2022, -$69,820 in the year ended Dec 31, 2021, -$55,947 in the year ended Dec 31, 2020 and -$297,901 in the year ended Dec 31, 2019.
- Five-year quarterly Income from Non-Controlling Interests spans a low of -$14.56 million in the quarter ended Jun 30, 2025 and a high of $315,691 in the quarter ended Sep 30, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.00 Mn |
| 10 | ProQR Therapeutics | 138.02 Mn | -322.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 315,691.24 |
| Jun 30, 2023 | 17,422.79 |
| Mar 31, 2023 | 83,720.66 |
| Dec 31, 2022 | -3,060.74 |
| Sep 30, 2022 | 14,115.84 |
| Jun 30, 2022 | 231,551.30 |
| Mar 31, 2022 | -8,978.70 |
| Dec 31, 2021 | -21,735.45 |
| Sep 30, 2021 | -25,944.32 |
| Jun 30, 2021 | -8,429.90 |
| Mar 31, 2021 | -13,268.60 |
| Dec 31, 2020 | -13,115.19 |
| Sep 30, 2020 | -9,344.62 |
| Jun 30, 2020 | -7,710.22 |
| Mar 31, 2020 | -25,390.60 |
| Dec 31, 2019 | -49,809.95 |
| Sep 30, 2019 | -57,861.96 |
| Jun 30, 2019 | -92,138.41 |
| Mar 31, 2019 | -98,886.71 |
| Dec 31, 2018 | -65,059.60 |
API Access
ProQR Therapeutics Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PRQR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PRQR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PRQR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();